Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

"Temples to Christ's indwelling": forms of chastity in a Barking Abbey manuscript.

Rice NR.

J Hist Sex. 2010 Jan;19(1):115-32. No abstract available.

PMID:
20422777
2.

A novel cell-based system for the rapid quantitative evaluation of (anti)-inflammatory potential of test substances.

Kozlov SV, Dobrovolskaia MA, Rice NR, Stewart CL, Vogel SN.

J Immunol Methods. 2003 Oct 1;281(1-2):51-63.

PMID:
14580881
3.

Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.

Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, Cody MJ, Michalek SM, Rice NR, Vogel SN.

J Immunol. 2003 Jan 1;170(1):508-19.

4.

Cyclosporin A blocks the expression of lymphotoxin alpha, but not lymphotoxin beta, in human peripheral blood mononuclear cells.

Kuprash DV, Boitchenko VE, Yarovinsky FO, Rice NR, Nordheim A, Rühlmann A, Nedospasov SA.

Blood. 2002 Sep 1;100(5):1721-7.

PMID:
12176893
5.

Adenovirus type 5 vectors induce dendritic cell differentiation in human CD14(+) monocytes cultured under serum-free conditions.

Lyakh LA, Koski GK, Young HA, Spence SE, Cohen PA, Rice NR.

Blood. 2002 Jan 15;99(2):600-8.

PMID:
11781244
7.

CD14+ monocytes as dendritic cell precursors: diverse maturation-inducing pathways lead to common activation of NF-kappab/RelB.

Koski GK, Lyakh LA, Cohen PA, Rice NR.

Crit Rev Immunol. 2001;21(1-3):179-89. Review.

PMID:
11642603
9.

Role of NF-kappaB in p53-mediated programmed cell death.

Ryan KM, Ernst MK, Rice NR, Vousden KH.

Nature. 2000 Apr 20;404(6780):892-7.

PMID:
10786798
10.

E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways.

Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH.

Mol Cell. 1999 Nov;4(5):771-81.

11.

Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide.

Kuprash DV, Udalova IA, Turetskaya RL, Kwiatkowski D, Rice NR, Nedospasov SA.

J Immunol. 1999 Apr 1;162(7):4045-52.

12.

The N-terminal domain of IkappaB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers.

Latimer M, Ernst MK, Dunn LL, Drutskaya M, Rice NR.

Mol Cell Biol. 1998 May;18(5):2640-9.

13.
14.

Expression of NFAT-family proteins in normal human T cells.

Lyakh L, Ghosh P, Rice NR.

Mol Cell Biol. 1997 May;17(5):2475-84.

15.

I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.

Whiteside ST, Epinat JC, Rice NR, Israël A.

EMBO J. 1997 Mar 17;16(6):1413-26.

16.

IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice.

Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt PH, Chen CH, Rosen CA, Stewart CL.

Mol Cell Biol. 1996 May;16(5):2341-9.

17.

Activation of nuclear factor of activated T cells in a cyclosporin A-resistant pathway.

Ghosh P, Sica A, Cippitelli M, Subleski J, Lahesmaa R, Young HA, Rice NR.

J Biol Chem. 1996 Mar 29;271(13):7700-4.

18.

Identification of an I kappa B alpha-associated protein kinase in a human monocytic cell line and determination of its phosphorylation sites on I kappa B alpha.

Kuno K, Ishikawa Y, Ernst MK, Ogata M, Rice NR, Mukaida N, Matsushima K.

J Biol Chem. 1995 Nov 17;270(46):27914-9.

19.
20.
22.

Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells.

Bryan RG, Li Y, Lai JH, Van M, Rice NR, Rich RR, Tan TH.

Mol Cell Biol. 1994 Dec;14(12):7933-42.

23.

Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy.

Ghosh P, Sica A, Young HA, Ye J, Franco JL, Wiltrout RH, Longo DL, Rice NR, Komschlies KL.

Cancer Res. 1994 Jun 1;54(11):2969-72.

24.

Expression of v-src in T cells correlates with nuclear expression of NF-kappa B.

Eicher DM, Tan TH, Rice NR, O'Shea JJ, Kennedy IC.

J Immunol. 1994 Mar 15;152(6):2710-9.

PMID:
8144878
25.

The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes.

Klug CA, Gerety SJ, Shah PC, Chen YY, Rice NR, Rosenberg N, Singh H.

Genes Dev. 1994 Mar 15;8(6):678-87.

26.

In vivo control of NF-kappa B activation by I kappa B alpha.

Rice NR, Ernst MK.

EMBO J. 1993 Dec;12(12):4685-95.

27.

Expression and mutational analysis of the reverse transcriptase of the lentivirus equine infectious anemia virus.

Shaharabany M, Rice NR, Hizi A.

Biochem Biophys Res Commun. 1993 Oct 29;196(2):914-20.

PMID:
7694581
28.
29.

The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65.

Ghosh P, Tan TH, Rice NR, Sica A, Young HA.

Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1696-700.

31.

Characterization of a new tissue-specific transcription factor binding to the simian virus 40 enhancer TC-II (NF-kappa B) element.

Lattion AL, Espel E, Reichenbach P, Fromental C, Bucher P, Israël A, Baeuerle P, Rice NR, Nabholz M.

Mol Cell Biol. 1992 Nov;12(11):5217-27.

32.

The precursor of NF-kappa B p50 has I kappa B-like functions.

Rice NR, MacKichan ML, Israël A.

Cell. 1992 Oct 16;71(2):243-53.

PMID:
1423592
33.

Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel.

Tan TH, Huang GP, Sica A, Ghosh P, Young HA, Longo DL, Rice NR.

Mol Cell Biol. 1992 Sep;12(9):4067-75.

34.

v-rel- and c-rel-protein complexes bind to the NF-kappa B site in vitro.

Kochel T, Rice NR.

Oncogene. 1992 Mar;7(3):567-72.

PMID:
1549370
35.

Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation.

Perkins ND, Schmid RM, Duckett CS, Leung K, Rice NR, Nabel GJ.

Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1529-33.

36.

Alterations at the rel locus in human lymphoma.

Lu D, Thompson JD, Gorski GK, Rice NR, Mayer MG, Yunis JJ.

Oncogene. 1991 Jul;6(7):1235-41.

PMID:
1650444
37.

The v-rel and c-rel proteins exist in high molecular weight complexes in avian and murine cells.

Kochel T, Mushinski JF, Rice NR.

Oncogene. 1991 Apr;6(4):615-26.

PMID:
1851550
38.

Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus.

Rice NR, Henderson LE, Sowder RC, Copeland TD, Oroszlan S, Edwards JF.

J Virol. 1990 Aug;64(8):3770-8.

39.
40.

Viral DNA in horses infected with equine infectious anemia virus.

Rice NR, Lequarre AS, Casey JW, Lahn S, Stephens RM, Edwards J.

J Virol. 1989 Dec;63(12):5194-200.

41.

A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon.

Brownell E, Mittereder N, Rice NR.

Oncogene. 1989 Jul;4(7):935-42.

PMID:
2666912
43.

Regional localization of the human c-rel locus using translocation chromosome analysis.

Brownell E, Fell HP, Tucker PW, Geurts van Kessel AH, Hagemeijer A, Rice NR.

Oncogene. 1988 May;2(5):527-9.

PMID:
3287280
44.
45.

Expression of the bovine leukemia virus X region in virus-infected cells.

Rice NR, Simek SL, Dubois GC, Showalter SD, Gilden RV, Stephens RM.

J Virol. 1987 May;61(5):1577-85.

46.

Characterization of equine infectious anemia virus long terminal repeat.

Derse D, Dorn PL, Levy L, Stephens RM, Rice NR, Casey JW.

J Virol. 1987 Mar;61(3):743-7.

47.

Detection of c-rel-related transcripts in mouse hematopoietic tissues, fractionated lymphocyte populations, and cell lines.

Brownell E, Mathieson B, Young HA, Keller J, Ihle JN, Rice NR.

Mol Cell Biol. 1987 Mar;7(3):1304-9.

48.

Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus.

Rein A, McClure MR, Rice NR, Luftig RB, Schultz AM.

Proc Natl Acad Sci U S A. 1986 Oct;83(19):7246-50.

49.

Comparative genetic mapping of cellular rel sequences in man, mouse, and the domestic cat.

Brownell E, Kozak CA, Fowle JR 3rd, Modi WS, Rice NR, O'Brien SJ.

Am J Hum Genet. 1986 Aug;39(2):194-202.

50.

Supplemental Content

Support Center